When and How To Perform Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer.
Eur Urol Focus
; 9(4): 564-566, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37059619
Active surveillance (AS) has been proposed as a possible management option for patients with recurrent low-grade non-muscle-invasive bladder cancer. Recent studies suggest that AS is a safe and effective management strategy. Nevertheless, a consensus statement is needed to standardize inclusion criteria and follow-up schedules.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Non-Muscle Invasive Bladder Neoplasms
Type of study:
Etiology_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
Eur Urol Focus
Year:
2023
Document type:
Article
Country of publication: